Knight Therapeutics
Denys Kurilko has over 10 years of progressive experience in audit and assurance services. Denys has worked at EY from 2008 to 2021, starting as an Assurance Senior and moving up to an Assurance Manager. During their time at EY, Denys managed large scale, complex public engagements for Fortune 500 companies and supported high-performance, cross-functional, and multi-location teams. Denys has experience in the full audit lifecycle, including budgeting, planning, and execution. Currently, Denys is the Director of Finance and Financial Reporting at Knight Therapeutics Inc.
Denys Kurilko CPA US, FCCA completed their education at ACCA from 2007 to 2012. Denys obtained a degree in Finance with a Masters from Ukraine Jobs. The specific degree obtained from CPA US is not mentioned.
This person is not in any offices
Knight Therapeutics
1 followers
Knight Therapeutics Inc. is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals in Canada and Latin America. Headquartered in Montreal, Knight has operations in Canada and in 10 countries in Latin America and has over 700 employees globally. Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD.